Approval · Notice of Compliance 25439 · 2021
VENTOLIN HFA: Notice of Compliance 25439
Issued March 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25439
- Date
- March 16, 2021
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To add a manufacturer pharmacopoeial standard and to update the common name in the Product Monograph and package labels as well as other label revisions
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VENTOLIN HFA | Not yet assigned | — |
Medicinal ingredients
- SALBUTAMOL SULFATE 100 MCG per ACT